DSCO isn't going out of business by Spring. Spring is too early. They have cash through the 2nd quarter. Hence their need to dilute before the first quarter is over. Probably too risky to wait until the 2nd qtr and the Surfaxin launch.... what if the FDA raises questions and causes a delay? Any further delay, any additional burp, any hint of a hiccup and this baby is streaking for a crater.
The chances of this group toughing it out until the launch are extremely remote. Traditionally this group dilutes late in the 4th quarter to middle of the first quarter. No reason to expect any change in modus at this time. I'll wait.
It's the end of November and I haven't even seen an launch of the nozzle yet. The Afectair nozzle was authorized for sale by the FDA 9 months ago, last February, before Surfaxin was approved. The Afectair nozzle was supposed to work with a number of existing fluids and drugs and existing equipment now in hospitals... and be usable and useful without Surfaxin. Yet they don't seem to have been able to get their contract manufacturer to produce, package and ship any yet.They obviously have at least one set of molds because they produced something to show to the FDA last year to get approval. It's not like this economy has been conducive to long lead times on mold blocks. Had they been focused on what they were doing, the world would be awash in Afectair nozzles by now. Maybe there is a shortage of plastic bags to ship them in.... Maybe the nozzle does not work with other drugs.... maybe it only works with Surfaxin? Otherwise, how come it hasn't been launched yet??? It isn't going to make any real money, but it would be a positive if they could just get something done on time instead of at the last possible moment... or late.